More PRNewswire
View Older Stories View Newer Stories-
FEDERAL CONTRACEPTION PROPOSAL TO EXPAND ACCESS AND AFFORDABLE COVERAGE PAVES A STRONGER PATH FOR MAYNE PHARMA'S GROWTH IN WOMEN'S HEALTH
-
Samsonite commits to science-based climate target to maintain 100% renewable electricity in own operations and significantly reduce value chain emissions by 2030
-
MDA SPACE ANNOUNCES APPOINTMENT OF GUILLAUME LAVOIE AS CHIEF FINANCIAL OFFICER
-
Protiviti-Oxford University Survey Finds Only 8% of Global Business Leaders Have Serious Concerns About Their Organizations' Ability to Protect Customer Data
-
Movano Health Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split
-
Virtusa recognized as a Leader in Everest Group's Application Management Services PEAK Matrix™ Assessment for Mid-market Enterprises
-
Shamrock Capital Raises $1.6 Billion for Sixth Private Equity Flagship and Inaugural Small Cap Funds
-
TTX COMPANY APPOINTS MARTY THOMAS AS EXECUTIVE VICE PRESIDENT
-
CBAK Energy to Report Third Quarter 2024 Unaudited Financial Results on Tuesday, November 12, 2024
-
Signal Hill Equity Partners Establishes New Architecture and Engineering Services Platform Focused on Serving Social Infrastructure End Markets
-
OneLayer Recognized as a Cool Vendor in the 2024 Gartner® Cool Vendors™ in CPS Security
-
Construction Partners, Inc. Announces Closing of Lone Star Paving Acquisition
-
Your Food is Failing You: An At-Home DNA Test Can Show You What's Missing
-
Oxipital AI Unveils Next-Generation VX2 Vision System: Smaller, More Powerful, and More Affordable
-
DICK'S Sporting Goods Third Quarter Results Call Scheduled for November 26th
-
Odyssey Systems awarded $531M U.S. Air Force contract to support ISR & SOF Directorate
-
In latest interoperability expansion, Epic advances personalized care
-
Acarix Expands U.S. Reimbursement Coverage for CADScor System for use in Emergency and Outpatient Settings
-
OncoResponse to Present Phase 1 Results of Clinical Study of OR502, anti-LILRB2 Antibody, as a Late-Breaker Poster Presentation at SITC 2024
-
The ActivPanel 10 is coming: Promethean's next-gen experience is built with choice and simplicity in mind
-
Demandbase Releases 2024 State of B2B Advertising Report: AI, ABM, and Personalization Lead Industry Evolution
-
Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value
-
Midwest Autism & Therapy Centers Hosts Minnesota State Legislators to Promote Autism Awareness and Local Treatment Options
-
Autodesk extends invitation to join financial results conference call
-
Bracco Diagnostics Inc. Showcases Innovations and More at RSNA 2024 Annual Meeting
-
Tailift Shines at FABTECH 2024, Forging Global Partnerships to Drive the Future of Intelligent Manufacturing
-
One Rock Capital Partners Completes Sale of ArchKey Solutions
-
Davidson Hospitality Group Tapped by Lennox Capital Partners to Manage Two Distinctive Hotels
-
PRIVACY ALERT: OnePoint Patient Care Under Investigation for Data Breach of Over 795,000 Patient Records
-
Over 100 Top Leaders & Veterans Issue Bipartisan Statement on Election Day Calling for America's Trust in Elections and Peaceful Transfer of Power
-
WINSTAR REMAINS OPTIMISTIC BEFORE THE US ELECTIONS
-
Damona Pharmaceuticals Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of DPX-101, a Positive Allosteric Modulator Targeting the α5-GABA-A Receptor Subtype Selectively, with B
-
Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED
-
PRIVACY ALERT: Landmark Admin Under Investigation for Data Breach of Over 806,000 Life Insurance Policyholders' Records
-
WELL Health to Acquire Canadian Clinical Assets of Jack Nathan Health and Begin Operating Clinics in Wal-Mart Stores to Grow Healthcare Clinic Network Across Canada
-
A Helene Affected Asheville Spa Comes Up With Inspirational Strategy To Support Community
-
A new lens on Guangxi
-
Kazia Therapeutics Announces Granting of Type C Meeting with FDA to Discuss Potential Next Steps for Paxalisib in the Treatment of Newly Diagnosed Glioblastoma Multiforme
-
Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors
-
PSEG ANNOUNCES THIRD QUARTER 2024 RESULTS
-
COVE COMMUNITIES POISED FOR CONTINUED GROWTH
-
SOUTHWEST AIRLINES NAMES RAKESH GANGWAL CHAIR OF THE BOARD AND ANNOUNCES NEW COMMITTEE CHAIRS
-
Renovus Capital Partners Announces Majority Investment in Performive
-
HelixVM™ Featured in Prestigious JMIR Publication, Recognized as GrowFL Award Finalist
-
Scripps reports Q3 2024 financial results
-
Palatin Presents Data on Novel Melanocortin 4 Receptor Selective Oral Small Molecule PL7737 Obesity Program at ObesityWeek® 2024
-
CME Group Reports October 2024 ADV of 24.3 Million Contracts
-
HYZON ANNOUNCES COMPLETION OF SUCCESSFUL TRIAL OF 200kW CLASS 8 FCEV TRUCK WITH IMC LOGISTICS
-
Hertz Global Holdings, Inc. to Announce Third Quarter 2024 Financial Results on November 12, 2024
-
Ripjar Appoints Tom Obermaier as CEO as Long Ridge Equity Partners Completes a Follow-On Majority Growth Investment
